143 related articles for article (PubMed ID: 34999721)
1. Vitreoretinal lymphoma: Central nervous system lymphoma risk with unilateral or bilateral ocular tumour. A multicentre collaboration.
Dalvin LA; Pulido JS; Shields CL; Marchese A; Miserocchi E; Frenkel S; Pe'er J
Eye (Lond); 2023 Jan; 37(1):54-61. PubMed ID: 34999721
[TBL] [Abstract][Full Text] [Related]
2. Clinical Features Predictive of Survival in Patients With Vitreoretinal Lymphoma: Analysis of 70 Patients at a Single Ocular Oncology Center.
Dalvin LA; Lim LS; Ancona-Lezama D; Mazloumi M; Chang M; Porcu P; Martinez NL; Glass J; Mashayekhi A; Shields CL
Asia Pac J Ophthalmol (Phila); 2020; 9(2):110-116. PubMed ID: 31923035
[TBL] [Abstract][Full Text] [Related]
3. Tumor Control and Visual Acuity Outcomes in Vitreoretinal Lymphoma with and without Sub-Retinal Pigment Epithelium Infiltration: Analysis of 125 Eyes of 70 Patients at a Single Ocular Oncology Center.
Dalvin LA; Lim LS; Ancona-Lezama D; Mazloumi M; Chang M; Mashayekhi A; Shields CL
Ophthalmol Retina; 2019 Nov; 3(11):998-1005. PubMed ID: 31358444
[TBL] [Abstract][Full Text] [Related]
4. Relationship between vitreoretinal lymphoma and the site of lymphoma development in the central nervous system.
Maruyama K; Iwahashi C; Hashida N; Ohguro N; Nishida K
Jpn J Ophthalmol; 2022 Mar; 66(2):142-150. PubMed ID: 34860298
[TBL] [Abstract][Full Text] [Related]
5. Advanced OCT Analysis of Biopsy-proven Vitreoretinal Lymphoma.
Pichi F; Dolz-Marco R; Francis JH; Au A; Davis JL; Fawzi A; Gattousi S; Goldstein DA; Keane PA; Miserocchi E; Marchese A; Ohno-Matsui K; Sagoo MS; Smith SD; Sobol EK; Tasiopoulou A; Yang X; Shields CL; Freund KB; Sarraf D
Am J Ophthalmol; 2022 Jun; 238():16-26. PubMed ID: 34843686
[TBL] [Abstract][Full Text] [Related]
6. Role of systemic high-dose methotrexate and combined approaches in the management of vitreoretinal lymphoma: A single center experience 1990-2018.
Castellino A; Pulido JS; Johnston PB; Ristow KM; Nora Bennani N; Inwards DJ; Macon WR; Micallef INM; King RL; Salomao DR; Witzig TE; Habermann TM; Nowakowski GS
Am J Hematol; 2019 Mar; 94(3):291-298. PubMed ID: 30516868
[TBL] [Abstract][Full Text] [Related]
7. Clinical Features and Treatment Outcomes of Vitreoretinal Lymphoma according to Its Association with CNS Lymphoma.
Cho BJ; Kim DY; Park UC; Lee JY; Yoon YH; Yu HG
Ocul Immunol Inflamm; 2018; 26(3):365-371. PubMed ID: 29394118
[TBL] [Abstract][Full Text] [Related]
8. Curious case of bilateral non-resolving vitritis - Unmasking the masquerade on ultra-widefield imaging.
Delhiwala K
Indian J Ophthalmol; 2022 Apr; 70(4):1438-1439. PubMed ID: 35326082
[TBL] [Abstract][Full Text] [Related]
9. Diagnosis and management of vitreoretinal lymphoma: present and future treatment perspectives.
Kaburaki T; Taoka K
Jpn J Ophthalmol; 2023 Jul; 67(4):363-381. PubMed ID: 37209195
[TBL] [Abstract][Full Text] [Related]
10. Next generation sequencing of vitreoretinal lymphomas from small-volume intraocular liquid biopsies: new routes to targeted therapies.
Cani AK; Hovelson DH; Demirci H; Johnson MW; Tomlins SA; Rao RC
Oncotarget; 2017 Jan; 8(5):7989-7998. PubMed ID: 28002793
[TBL] [Abstract][Full Text] [Related]
11. SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY FEATURES OF VITREORETINAL LYMPHOMA IN 55 EYES.
Yang X; Dalvin LA; Mazloumi M; Ferenczy S; Lim LS; Ancona-Lezama D; Shields JA; Mashayekhi A; Shields CL
Retina; 2021 Feb; 41(2):249-258. PubMed ID: 32349103
[TBL] [Abstract][Full Text] [Related]
12. Clinical Experience in a Large Cohort of Patients with Vitreoretinal Lymphoma in a Single Center.
Giuffrè C; Cicinelli MV; Marchese A; Modorati GM; Brambati M; Ferreri AJM; Calimeri T; Ponzoni M; Bandello F; Miserocchi E
Ocul Immunol Inflamm; 2021 Apr; 29(3):472-478. PubMed ID: 32845738
[No Abstract] [Full Text] [Related]
13. Long-term outcomes of combined intravitreal methotrexate and systemic high-dose methotrexate therapy in vitreoretinal lymphoma.
Cheng CL; Yeh PT; Fang WQ; Ma WL; Hou HA; Tsai CH; Lin CP; Tien HF
Cancer Med; 2023 Apr; 12(7):8102-8111. PubMed ID: 36602288
[TBL] [Abstract][Full Text] [Related]
14. Vitreoretinal presentation of secondary large B-cell lymphoma in patients with systemic lymphoma.
Salomão DR; Pulido JS; Johnston PB; Canal-Fontcuberta I; Feldman AL
JAMA Ophthalmol; 2013 Sep; 131(9):1151-8. PubMed ID: 23744124
[TBL] [Abstract][Full Text] [Related]
15. Eye involvement in primary central nervous system lymphoma.
Farrall AL; Smith JR
Surv Ophthalmol; 2020; 65(5):548-561. PubMed ID: 32057762
[TBL] [Abstract][Full Text] [Related]
16. Association between ocular findings and preventive therapy with onset of central nervous system involvement in patients with primary vitreoretinal lymphoma.
Hashida N; Nakai K; Saitoh N; Nishida K
Graefes Arch Clin Exp Ophthalmol; 2014 Apr; 252(4):687-93. PubMed ID: 24549401
[TBL] [Abstract][Full Text] [Related]
17. Aurora borealis and string of pearls in vitreoretinal lymphoma: patterns of vitreous haze.
Marchese A; Miserocchi E; Giuffrè C; Cicinelli MV; Querques G; Bandello F; Modorati G
Br J Ophthalmol; 2019 Nov; 103(11):1656-1659. PubMed ID: 30709808
[TBL] [Abstract][Full Text] [Related]
18. Survival and Recurrence in Vitreoretinal Lymphoma Simulating Uveitis at Presentation: The Possible Role of Combined Chemotherapy.
Gozzi F; Aldigeri R; Mastrofilippo V; De Simone L; Bolletta E; Marzano J; Iannetta D; Coassin M; Ilariucci F; Ferrari A; Luminari S; Merli F; Croci S; Zerbini A; Farnetti E; Nicoli D; Valli R; Tamagnini I; Cavazza A; Salvarani C; Fontana L; Cimino L
Ocul Immunol Inflamm; 2022; 30(7-8):1833-1841. PubMed ID: 34379571
[TBL] [Abstract][Full Text] [Related]
19. Spectral-domain optical coherence tomography biomarkers in vitreoretinal lymphoma.
Guan W; Xiao Y; Zhao H; Hu F; Chen C; Peng X
Clin Exp Ophthalmol; 2023 Mar; 51(2):144-153. PubMed ID: 36567492
[TBL] [Abstract][Full Text] [Related]
20. Vitreoretinal lymphoma: a 20-year review of incidence, clinical and cytologic features, treatment, and outcomes.
Levasseur SD; Wittenberg LA; White VA
JAMA Ophthalmol; 2013 Jan; 131(1):50-5. PubMed ID: 23307208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
